Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Operating Activities:
Net income attributable to Fortegra Financial Corporation	$ 2,898	$ 2,493
Adjustments to reconcile net income to net cash flows (used in) operating activities:
Change in deferred acquisition costs	6,380	(4,303)
Depreciation and amortization	2,566	3,266
Deferred income tax (benefit) expense - continuing operations	(263)	860
Deferred income tax expense - discontinued operations	0	186
Net realized investment gains	(1)	(7)
Loss on note receivable	1,317	0
Stock-based compensation expense	292	303
Direct stock awards to employees	1	2
Amortization of premiums and accretion of discounts on investments	437	350
Non-controlling interests	861	818
Change in allowance for doubtful accounts	(162)	11
Changes in operating assets and liabilities, net of the effects of acquisitions and dispositions:
Accrued investment income	27	56
Accounts and premiums receivable, net	(1,746)	(6,868)
Other receivables	4,921	(14,678)
Reinsurance receivables	4,184	7,281
Income taxes receivable	0	(375)
Other assets	(172)	(887)
Unpaid claims	1,900	948
Unearned premiums	(7,027)	(10,612)
Policyholder account balances	(478)	(534)
Accrued expenses, accounts payable and other liabilities	(9,809)	12,592
Income taxes payable	(1,080)	0
Deferred revenue	(7,570)	7,803
Change in liabilities of discontinued operations	(7,367)	0
Net cash flows (used in) operating activities	(9,891)	(1,295)
Investing activities:
Proceeds from maturities, calls and prepayments of available-for-sale investments	16,263	3,332
Proceeds from sales of available-for-sale investments	501	412
Purchases of available-for-sale investments	(20,267)	(10,199)
Purchases of property and equipment	(816)	(993)
Net paid for acquisitions of subsidiaries, net of cash received	20	(2,902)
Net (issuance) from notes receivable	(5,162)	0
Net proceeds from notes receivable	0	110
Net proceeds from related party note receivable	0	6,135
Change in restricted cash, net of restricted cash (paid) received from acquisitions and divestitures	(559)	2,261
Net cash flows (used in) investing activities	(10,020)	(1,844)
Financing activities:
Payments on notes payable	(23,484)	(8,188)
Proceeds from notes payable	33,376	10,500
Distributions to non-controlling interest partners	(688)	0
Dividends paid to non-controlling interests	0	(43)
Net cash flows provided by financing activities	9,204	2,269
Net (decrease) in cash and cash equivalents	(10,707)	(870)
Cash and cash equivalents, beginning of period	21,681	31,339
Cash and cash equivalents, end of period	$ 10,974	$ 30,469